Research summary, narrative review, 2026

A Narrative Review of Cancer Risks in Medical Radiation Workers Across High- and Low-Dose Practice Eras: Implications for Radiation Protection

Taibu RN, Mataka LM. Journal of radiological protection : official journal of the Society for Radiological Protection. 2026

Read the original paper

In plain language

Medical radiation workers in early high-dose eras had higher rates of breast, blood and skin cancers. Modern low-dose cohorts show small, uncertain risk estimates. This review found no consistent sex differences, and low-dose risk remains hard to measure.

At a glance

Type of study
Narrative review
Who was studied
Mixed lab staff
Summary based on
the abstract

What it found

  • Cohorts from early high-dose practice eras consistently show elevated risks of radiosensitive cancers among medical radiation workers.

  • Contemporary cohorts working under current protection standards accumulate low doses and show small, often non-significant dose-response estimates.

  • Limited statistical power at low doses makes excess risks hard to detect and leaves the shape of the dose-response unclear.

  • The evidence does not show consistent sex-based differences in radiation-related cancer risk at occupational exposure levels.

  • Epidemiologic methods have moved from proxy exposure indicators to quantitative dose-response modelling, supported by better dosimetry and organ-dose reconstruction.

Limits to keep in mind

This is a narrative rather than a systematic review, and only the abstract was available, so the number of studies and the effect sizes are not reported. Its conclusions rest on underpowered low-dose cohorts that are not specific to interventional fluoroscopy staff.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.